Seres Therapeutics, Inc.

Seres Therapeutics sets November 4 results date for MCRB stock
AD HOC NEWS · 20 Oct 2026
Potential biomarkers presented by Seres Therapeutics to predict patient outcomes
Traders Union · 19 Oct 2026
Seres to present preclinical data on SER-428 at IDWeek 2026
Investing.com UK · 15 Oct 2026
Seres Therapeutics to Present Preclinical Data for
GlobeNewswire · 15 Oct 2026
Seres Therapeutics completes 25 million dollar milestone buyout from Nestlé Health Science
Traders Union · 08 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.